CAZZANIGA MARINA ELENA

Ruolo:

Ricercatore a tempo determinato

Settore scientifico disciplinare:

ONCOLOGIA MEDICA (MED/06)

Afferenza:

E-mail:

Bani, M., Rossi, E., Cortinovis, D., Russo, S., Gallina, F., Hillen, M., et al. (2021). Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale. EUROPEAN JOURNAL OF CANCER CARE, 30(1). Dettaglio
Zeppellini, A., Galimberti, S., Leone, B., Pacifico, C., Riva, F., Cicchiello, F., et al. (2021). Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study. BMC CANCER, 21(1), 260-270. Dettaglio
Caruso, A., Caccuri, F., Bugatti, A., Zani, A., Vanoni, M., Bonfanti, P., et al. (2021). Methotrexate inhibits SARS-CoV-2 virus replication "in vitro". JOURNAL OF MEDICAL VIROLOGY, 93(3), 1780-1785. Dettaglio
Krasniqi, E., Pizzuti, L., Barchiesi, G., Sergi, D., Carpano, S., Botti, C., et al. (2020). Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence. JOURNAL OF CELLULAR PHYSIOLOGY, 235(11), 7900-7910. Dettaglio
Jacobs, S., Robidoux, A., Abraham, J., Pérez-Garcia, J., La Verde, N., Orcutt, J., et al. (2020). Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer. BREAST CANCER RESEARCH, 22(1). Dettaglio

Futuri studenti - Iscrizioni